The Complement Response Against an Oncolytic Virus Is Species-Specific in Its Activation Pathways-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Complement Response Against an Oncolytic Virus Is Species-Specific in Its Activation Pathways

Published:2002-03 Issue:3 Volume:5 Page:275-282
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Wakimoto Hiroaki,Ikeda Keiro,Abe Tatsuya,Ichikawa Tomotsugu,Hochberg Fred H,Ezekowitz R.Alan B,Pasternack Mark S,Chiocca E.Antonio

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference44 articles.

1. Oncolytic viruses as novel anticancer agents: turning one scourge against another;Chiocca;Expert Opin. Investig. Drugs,2000

2. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial;Markert;Gene Ther.,2000

3. Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins;Andreansky;Gene Ther.,1998

4. An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy;Chase;Nat. Biotechnol.,1998

5. Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses;Ikeda;Nat. Med.,1999

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress in combination therapy of oncolytic vaccinia virus;Frontiers in Immunology;2024-03-13

2. Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer;Molecular Therapy: Oncology;2024-03

3. Oncolytic virotherapy in cancer treatment: challenges and optimization prospects;Frontiers in Immunology;2023-12-15

4. Oncolytic viruses against cancer, promising or delusion?;Medical Oncology;2023-07-17

5. Therapy with oncolytic viruses: progress and challenges;Nature Reviews Clinical Oncology;2023-01-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3